41-year-old man has complications due to corona virus infection.
Chinese man died in Singapore two weeks after being cured of Covid-19 infection. The Singapore Ministry of Health said the 41-year-old man had complications due to corona virus infection.The Singapore Ministry of Health announced the man’s death on Saturday 6 June 2020. The man who was a patient of 11,714 cases died on Thursday 4 June 2020. He became a patient who died because of complications due to Covid-19.The man was declared cured of Covid-19 infection on May 17 last. But on June 4, the unidentified man fainted and was declared dead due to thromboembolism or massive blood clots in the lungs due to Covid-19 infection.Pulmonary embolism is a blockage in one of the arteries in the lungs. In most cases, pulmonary embolism is caused by blood clots that travel to the lungs from veins in the legs or from other parts of the body.
1 of 2 pages
On May 20, 2020, Singapore issued a warning to doctors about the risk. According to Singapore’s Minister of Health, Gan Kim Yong, doctors have been advised to be “on guard” for cardiovascular symptoms in Covid-19 patients, and to provide guidance on patient evaluation and treatment.Gan Kim Yong added, nearly one in a thousand patients experience cardiovascular conditions, such as heart attacks and blood clots.Citing international data, Gan Kim Yong added that Covid-19 patients treated in intensive care units were at higher risk, “because they cannot move for a long time and may have some concomitant diseases.”Under these conditions, added Gan Kim Yong, doctors in Singapore were advised, “take extra precautions such as monitoring [the tendency of blood clots] closely.”
2 of 2 pages
In some cases, anticoagulants or blood thinners are used to prevent blood clots. “However, the use of anti-coagulants must be considered against the risk of bleeding, and our doctors will decide on a case-by-case basis,” Gan added.Because Covid-19 is a new disease, continued Gan Kim Yong, Singapore learns more as time passes. The Ministry of Health will continue to monitor emerging evidence, and work with clinical experts to ensure the best care and results for Covid-19 patients.